Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
18%(2 trials)

Phase Distribution

Ph not_applicable
6
55%
Ph early_phase_1
1
9%
Ph phase_1
1
9%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (12.5%)
Phase 11 (12.5%)
N/A6 (75.0%)

Trials by Status

completed11100%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11